The FDA is recalling IV bags in several states due to fiberglass contamination, with tiny, sharp glass particles potentially getting injected into patients.



The company traces its roots to a 1999 merger between the pharmaceutical subsidiary of Fresenius and Kabi Pharmacia, a Swedish firm renowned for anesthesia and intensive care expertise.